22-11-2011 14:08 From the Majority Report, live MF 11:30am EST and via daily podcast at Majority.FM Lee Doren answers Sam Seder's Libertarian Open Challenge on Sam's 12 Hour 1 Year Anniversary Live Broadcast. A Libertarian vs. Leftist debate!
Go here to see the original:
24-02-2012 02:34 This is the video with my entire keynote speech (67 minutes) from the Future with High Speed Broadband Conference in Auckland, New Zealand on February 23, 2012. Topics: Transformational Technologies and Creating new demand for ICT services - The Future of Broadband and ICT -, in detail: the coming telemedia convergence, the future of content in a hyper-connected society, social networks are cable TV without the cable, why open standards are crucial, why and how data is the new oil, how Control is being replaced by engagement and involvement, why sustainability becomes even more important, the shift from egosystems versus ecosystems, the new drivers of Innovation http://www.futurebroadband.co.nz You can download the slides via http://www.slideshare.net
The rest is here:
Broadband Futures and the Future of ICT: Futurist and Keynote Speaker Gerd Leonhard - Video
31-10-2011 06:26 Capt. Blair fishes for cobia on the beaches of Florida's Space Coast with good friend, Capt. Scott Lum. Get the GEAR the MOGAN MAN uses @ http://www.addictivefishing.com Stay Connected @ addictivefishing.blogspot.com
View post:
20-01-2012 11:43 bigthink.com Dr. Michio Kaku: At night when you look at the stars and you look at the constellations and you wonder "Is anyone out there?" just realize that somebody out there could be looking back at us and wondering "Gee, is there any life on this ...
Read the original here:
The Holy Grail of Planetary Astronomy: The Search for Earth's Twin - Video
LONDON, March 28, 2012 /PRNewswire/ -- Based on its recent analysis of the in vitro diagnostics services market, Frost & Sullivan recognizes Targos Molecular Pathology GmbH with the 2011 European Frost & Sullivan Award for Customer Service Leadership. Targos is uniquely positioned to combine expertise in clinical and molecular pathology and highly standardised biomarker analysis with strict quality assurance.
Targos has superior time lines of service compared to its competitors, which have a turn-around-time (TAT) for not less than four days. Targos, on the other hand, has optimized the TAT for clinical tissue biomarker analysis to as low as 24 hours, enabling faster diagnostic test results and timely delivery of diagnostic services.
"The Targos team has proven its meticulousness, reliability and flexibility in handling small and very large projects to customers' satisfaction," said Frost & Sullivan Research Analyst Srinivas Sashidhar. "It provides a wide range of biomarker and other diagnostic services for histopathology, tissue analysis, expression profiling, enzyme-linked immunosorbent assay (ELISA) testing and related services including project, data and logistic management of biomarker studies."
Its services and expertise have appealed to customers, evidenced by the extension of long-term projects from 5 to 20 years. Targos' proficiency in in vitro diagnostics services has also allowed it to expand its customer base to more than 30 top pharmaceutical, biotech and diagnostic companies.
Targos has a well-organized cost structure, which can be tailored according to the project or service. The costs include project management, logistics management and data management fees. Its diagnostic service costs are lesser than its competitors'.
"The company has been inspected by the Food and Drug Administration (FDA) and participates in College of American Pathologists (CAP) proficiency testing and lab improvement programmes," notes Sashidhar. "Targos, in collaboration with its pathology partners, has acted as Good Clinical Practice-compliant patho-diagnostic reference centre for more than 75 pharmaco-diagnostic trials."
Each year, Frost & Sullivan presents this award to the company that demonstrates excellence in customer service leadership within its industry. The recipient company shows tremendous responsiveness to customer needs and continually focuses on long and short-term customer profitability goals. In addition, it demonstrates flexibility in tailoring its product offerings to suit customer businesses.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.
About Targos Molecular Pathology GmbH
Targos Molecular Pathology GmbH since 2005 has established itself as a preferred service provider for standardized analytics of clinical biomarkers. Targos central lab services allow its customers to perform global diagnostic and pharmaceutical approval trials under strict quality standards and lowest possible turn-around times for molecular pathology analyses. Targos thrives for steady improvement of service quality and portfolio and has currently 70 employees in three German sites.
Originally posted here:
Frost & Sullivan Acclaims Targos for Rapidly Establishing Itself as a Leader in Customer-Oriented Biomarker Services ...
RICHARDSON, TX--(Marketwire -03/28/12)- Interactive Family Clinic in Richardson, TX announced that the practice offers nutrition and weight loss services that are designed to naturally complement chiropractic care. Chiropractor Dr. Houssam Aljamal has been providing wellness care services to patients for nearly a decade. According to Dr. Aljamal, the right balance of nutrients can make a tremendous difference for patients' ability to successfully lose weight. The practice's weight loss program is designed to help reset patients' metabolism, so patients can successfully lose weight and keep the pounds off. The Richardson chiropractor also provides lifestyle advice, non-invasive laser surgery for weight loss, and chiropractic care for whole body wellness.
Richardson chiropractor Dr. Houssam Aljamal is raising awareness about the importance of nutrition counseling for successful weight loss and wellness care. Dr. Aljamal has over 10 years of experience providing patients with weight loss and nutrition counseling, in addition to chiropractic care for natural pain management.
"Our wellness center is committed to identifying and correcting underlying causes for chronic pain and disease," said Dr. Houssam Aljamal. "When a patient suffers from neck pain or back pain, we work to identify the underlying misalignment causing this pain. Here at our wellness center, we apply this same principle to successful weight loss. Each patient has individual nutrient needs. We identify these needs and work with patients to reset their metabolism, turning their bodies into fat burning machines."
Dr. Aljamal emphasized that the wellness center's weight loss program is not a "diet," but a roadmap to whole body wellness care. "Our program is not a 'quick fix' or a fad diet, but a series of permanent lifestyle changes," said Dr. Aljamal. "That's why our weight loss services are so successful -- we help patients reset their bodies and change their emotional response to food. With the right nutrients, food becomes fuel for the body, rather than a source of comfort or anxiety."
According to the Richardson chiropractor, nutrition counseling can also help patients who suffer from chronic back pain and headache. Some foods can "trigger" headaches or exacerbate existing pain. By switching to a low-inflammation diet high in antioxidants, patients may be able to use their diet to help control and reduce the occurrence of chronic pain.
"Antioxidants help combat chronic inflammation, which is a contributing factor for chronic back pain," said Dr. Aljamal. "We frequently recommend that our patients receive a combination of chiropractic adjustments and nutrition counseling. Together, these complementary treatments help reduce pain and enhance well-being."
In addition to nutrition counseling, the practice also provides non-invasive laser surgery for weight loss. This procedure is designed to remove fat and contours from the body without the cost or potential health complications of invasive procedures like liposuction.
"We've had tremendous success helping patients lose weight and reshape their bodies with body contouring procedures," said Dr. Aljamal. "Even with substantial natural weight loss, there are always pockets of stubborn fat on the body. Our body contouring procedures target these pockets for a slim, health overall appearance."
Interactive Family Clinic provides natural healing benefits for patients in Richardson and the surrounding areas of Garland, Carrollton, and University Park. Prospective patients may learn more about the nutrition and weight loss services offered by Interactive Family Clinic may visit the website at http://www.backtomyhealth.com.
Read the rest here:
Interactive Family Care Promotes Nutrition and Weight Loss Services to Enhance Benefits of Chiropractic Care, Promote ...
ROSELAND, N.J., March 28, 2012 /PRNewswire/ -- McDonald's New York Tri-State area restaurants today launched the McDonald's New York Metro Nutrition Network, a new community outreach initiative to provide funds to local organizations for grassroots nutrition programs. Through the program, New York Tri-State McDonald's restaurant owners are offering seed money to help local organizations bring nutrition information and guidance to the communities they serve. This initiative is an extension of McDonald's national commitment to offer improved nutrition choices.
In addition to providing seed funding to community organizations, McDonald's will host a series of offline MeetUps throughout the Tri-State area where registered dietitians can engage directly with families and individuals seeking nutrition information.
"As local business owners, we are committed to giving back to the communities we serve and this program helps us bring McDonald's nutrition commitments to our customers," said Anthony Scari, president of the McDonald's New York Tri-State Owner/Operators Association. "We look forward to celebrating those organizations whose projects help people make informed food choices."
The McDonald's "Commitments to Offer Improved Nutrition Choice" initiative strives to help customers make nutrition-minded choices. For example, McDonald's new Happy Meal includes both fruit (about1/4 cup apple slices) and a new smaller size French Fries (1.1 ounces). In support of the new Happy Meal, McDonald's has launched McDonald's Happy Meal Chefs Program, which gives parents and kids ages 8-11 the opportunity to collaborate with McDonald's own Executive Chef Dan to create new nutrition-minded Happy Meal choices.
"I salute McDonald's for expanding and improving its nutritionally-balanced menu choices and now for bringing nutritional guidance and information to the local community through this program. As a nutrition and diet expert, I know that improved well-being begins with incremental change, and I'm very excited to be part of this campaign to make nutritional information accessible to all," said Tanya Zuckerbrot, MS, RD, author of the best-selling The F Factor Diet.
McDonald's New York Metro Nutrition Network applications will be evaluated based on the impact of the proposed program on nutrition awareness in the community. This year, five organizations will be selected and each winning organization will be acknowledged with a presentation in their community. Tri-State area non-profit organizations can obtain an application at http://www.McDNYMetroNutritionNetwork.com. Completed applications should be mailed to: McDonald's Owners/Operators Association; Attention: McDonald's New York Metro Nutrition Network; PO Box 280; Little Falls, NJ 07424. The submission deadline is June 1, 2012.
ABOUT McDONALD'S NEW YORK TRI-STATE RESTAURANTS:
McDonald's is one of the world's best-known brands and is a global leader in food service. There are more than 600 McDonald's restaurants, owned by over 100 franchisees, located throughout the New York, New Jersey and Connecticut Tri-State area. Visit http://www.mcdonaldsnymetro.com or follow us on Twitter @McDNYTriState for information about other McDonald's area programs.
See the rest here:
McDonald's® Tri-State Owners Launch Local Nutrition Network to Support Community Programs
NEW YORK, March 28, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape
In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape
Summary
GBI Research's report, "In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape" provides key data, information and analysis on the global In Vitro Diagnostics (IVD) market. The report provides market landscape, competitive landscape and market trends information on seven IVD market categories: immunochemistry, clinical chemistry, infectious immunology, hematology, microbiology culture, histology and cytology and genetic testing. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, with analysis of the major Mergers and Acquisitions (M&A) in the last four years and a detailed analysis of the pipeline products in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.
Scope
- The key geographies include, the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- Market size data for seven In Vitro Diagnostics market categories immunochemistry, clinical chemistry, infectious immunology, hematology, microbiology culture, histology and cytology and genetic testing.
- Annualized market revenue data, seven-year forecasts through to 2018, as well as company share data for 2010.
Originally posted here:
In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the ...
Previously, I explored how to find the Golden Age of television by analyzing IMDb data. After I wrote this, Gabriel Rossman, an assistant of sociology at UCLA, noted that it would be interesting to see what this chart would look like if broken down by broadcast network. With Rossmans help (he also had been playing with the IMDb data), I was able to examine the average television show length over time, in number of episodes, for the different networks. A chart with the results is below:
Clearly, in the past decade or so, the number of episodes per show has calmed down quite a bit. My hunch is that this is due to the larger number of shows that are currently being aired, of which many get canceled, lowering the mean number of episodes. But if you look further back in time, you can see that network show longevity has hints of being a zero-sum game. When one network has long-lived shows during a time period, such as ABC in the mid-1980s, another network might have a series of duds, such as NBC during the same time. This is reasonable, as there is only a finite amount of collective attention that we can lavish on television watching. Therefore if one network is doing well, it is not surprising that others do more poorly. Of course, this metric is far from perfect, but it can be used to test further hypotheses.
You can also notice other things in this chart, such as even historical events. For example Rossman has pointed out to me that there are hints of the 1988 writers strike, displayed as a precipitous drop in show length, though the 2007 strike is invisible.
As Ive already noted, we are in the middle of a great time for television. Maybe its also a great time for the applied mathematics of television as well.
Top image: urbanora/Flickr/CC-licensed
Visit link:
Television Show Longevity by Network
Public release date: 28-Mar-2012 [ | E-mail | Share ]
Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 x2156 Mary Ann Liebert, Inc./Genetic Engineering News
New Rochelle, NY -- A novel method for printing human cells onto surfaces in defined patterns can help advance research on tissue engineering and regeneration, as described in an article in Tissue Engineering, Part C, Methods, a peer-reviewed journal from Mary Ann Liebert, Inc (http://www.liebertpub.com). The article is available free online at the Tissue Engineering website (http://www.liebertpub.com/ten).
"Cell printing is one of the breakthrough technologies that will make the application of stem cells for tissue engineering feasible," says John Jansen, DDS, PhD, Methods Co-Editor-in-Chief and Professor and Chairman, Department of Biomaterials, Radboud University Nijmegen Medical Center, The Netherlands.
Yu Fang and colleagues, University of Michigan, Ann Arbor, combined two microscale techniques to dispense and position cells in a variety of patterns. They then demonstrated the ability to use these 3-dimensional cell systems to monitor cell signaling events known to have a role in the growth, proliferation, and metastasis of cancer cells. The authors describe the use of sound waves to deliver microdroplets of cells and polymer-based phase separation to control cell placement in the article "Rapid Generation of Multiplexed Cell Co-Cultures Using Acoustic Droplet Ejection Followed by Aqueous Two-phase Exclusion Patterning." (http://online.liebertpub.com/doi/abs/10.1089/ten.TEC.2011.0709)
###
About the Journal
Tissue Engineering (http://www.liebertpub.com/ten) is an authoritative peer-reviewed journal published monthly in print and online in three parts: Part A--the flagship journal; Part BReviews; and Part CMethods. Led by Co-Editors-In-Chief Antonios Mikos, PhD, Louis Calder Professor at Rice University, Houston, TX, and Peter C. Johnson, MD, Vice President, Research and Development, Avery Dennison Medical Solutions of Chicago, IL and President and CEO, Scintellix, LLC, Raleigh, NC, the Journal brings together scientific and medical experts in the fields of biomedical engineering, material science, molecular and cellular biology, and genetic engineering. Tissue Engineering is the official journal of the Tissue Engineering & Regenerative Medicine International Society (TERMIS). Complete tables of content and a sample issue may be viewed online at the Tissue Engineering website (http://www.liebertpub.com/ten).
About the Company
Mary Ann Liebert, Inc.(http://www.liebertpub.com), is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Stem Cells and Development, Human Gene Therapy and HGT Methods, and Biopreservation and Biobanking. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available at Mary Ann Liebert Inc. (http://www.liebertpub.com).
Here is the original post:
Innovative cell printing technologies hold promise for tissue engineering R&D
Public release date: 28-Mar-2012 [ | E-mail | Share ]
Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News
New Rochelle, NY -- Online romance scams, a new form of cybercrime, is under-reported and increasing, and has victimized an estimated 230,000 people in England, costing them nearly $60 billion a year, according to an article in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal published by Mary Ann Liebert, Inc. The article is available free online at the Cyberpsychology, Behavior, and Social Networking website at http://www.liebertpub.com/cyber.
"This crime is very serious and unfortunately often overlooked. The costs to the victim are both hidden (emotional) and more visible (monetary)," says Brenda K. Wiederhold, PhD, MBA, BCIA, Editor-in-Chief of Cyberpsychology, Behavior and Social Networking, from the Interactive Media Institute, San Diego, CA.
Online dating scammers pretend to initiate a romantic relationship through online dating services and then defraud their victims of large sums of money over a period of months or longer. Monica Whitty, University of Leicester, UK, and Tom Buchanan, University of Westminster, London, UK, document the rapid growth in these serious crimes and how cybercriminals pursue and steal from their victims. They describe the devastating financial and emotional losses the victims suffer.
###
About the Journal
Cyberpsychology, Behavior, and Social Networking is an authoritative peer-reviewed journal published monthly in print and online that explores the psychological and social issues surrounding the Internet and interactive technologies. Complete tables of content and a sample issue may be viewed online at the Cyberpsychology, Behavior, and Social Networking website at http://www.liebertpub.com/cyber.
About the Company
Mary Ann Liebert, Inc. is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Games for Health Journal, Telemedicine and e-Health, and Journal of Child and Adolescent Psychopharmacology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc. website at http://www.liebertpub.com.
Original post:
Online dating scammers looking for money, not love
SAN DIEGO, March 28, 2012 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL - News) today announced that researchers at Ehime University in Japan and their collaborators have developed a Vaxfectin(R)-formulated DNA vaccine candidate with the potential to prevent transmission of malaria. Results of the initial testing, recently published in the journal Vaccine1, demonstrated that the malaria parasite life cycle was interrupted in mosquitoes fed with malaria-infected human red blood cells incubated with serum from vaccinated mice. Vical provided the DNA vaccine plasmid backbone and the adjuvant used in the research.
The malaria parasite advances through several life cycle stages in humans and through additional life cycle stages in mosquitoes. The transmission-blocking DNA vaccine candidate, formulated with Vical's Vaxfectin(R) adjuvant, expresses the Plasmodium vivax malaria parasite protein Pvs230, which is present in both human and mosquito stages of the parasite's life cycle. Anti-Pvs230 antibodies generated by vaccinated mice recognized the Pvs230 protein and interrupted the parasite's development in mosquitoes. The amino acid sequence of Pvs230 protein is also highly conserved among multiple field isolates of P. vivax, increasing the potential for a single vaccine to provide broad protection.
The mouse-generated Pvs230 antibodies, incubated with P. vivax-infected human red blood cells and then fed to mosquitoes, statistically reduced the number of parasites and the infection rate in mosquitoes. A Vaxfectin(R)-formulated malaria vaccine therefore has the potential to interfere with the transmission of P. vivax to humans through mosquitoes. This novel transmission-blocking approach may thereby protect the broader population from widespread malaria outbreaks. Further study of the vaccine candidate has been proposed by the authors.
About Vical
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs. Additional information on Vical is available at http://www.vical.com.
The Vical Incorporated logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5768
This press release contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected. Risks and uncertainties include whether any further development of a Vaxfectin(R)-formulated DNA vaccine for malaria will continue; whether malaria vaccine or other results in animal studies can be duplicated in human clinical trials; whether the malaria vaccine will be effective in blocking transmission of malaria through mosquitoes to humans; whether Vical or its collaborative partners will seek or gain approval to market any product candidates; whether Vical or its collaborative partners will succeed in marketing any product candidates; and additional risks set forth in the company's filings with the Securities and Exchange Commission. These forward-looking statements represent the company's judgment as of the date of this release. The company disclaims, however, any intent or obligation to update these forward-looking statements.
1Tachibana, M, et al. Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate. Vaccine 30 (2012) 1807-1812; doi:10.1016/j.vaccine.2012.01.003 .
More:
Novel Transmission-Blocking Malaria DNA Vaccine Candidate Uses Vical's Vaxfectin(R) Adjuvant
Murdered ... newsagent Min Lin and wife Lilly Lin. Source: The Daily Telegraph
NO DNA evidence has been found linking the man accused of the bashing murders of the Lin family to the crime, a court heard this morning.
The Supreme Court was told recent test results on items taken from the family's North Epping home had failed to provide any DNA connection to Robert Xie, 48, who was last year charged with the murders.
Xie has been accused of killing his brother-in-law, Epping newsagent Min Lin, his wife Yun Li "Lilly" Lin, two other family members and Lilly's sister Yun Bin "Irene" Lin.
The five family members were beaten to death inside their home on July 18, 2009.
Xie's barrister Graham Turnbull SC told a bail hearing this morning that none of his client's DNA had been found on any evidence found at the main crime scene.
"The deceased persons' DNA profile (also) hasn't been identified on any of the items belonging to (Xie) or as coming from his home address," he said.
Documents previously tendered in court revealed police found a bloody trail of footprints leading away from the crime scene.
Xie owned several pairs of ASICS runners that matched the footprints and he was later secretly filmed destroying boxes for the shoe, the prosecution said.
Police allege Xie acted alone in carrying out the killing.
Continue reading here:
No DNA linking man to Lin murders
March 28, 2012
A new genetic study confirms that modern domesticated cattle are descended from 80 domesticated wild oxen in the Near East over 10,500 years ago.
Scientists from CNRS, the National Museum of Natural History in France, the University of Mainz in Germany, and University College London (UCL) in the UK performed the study by extracting DNA from the bones of extracted domestic cattle found in Iran. These sites are believed to date back to the invention of farming and the area where cattle first became domesticated.
The international team of scientists found only small differences in the DNA from the Iranian excavation and modern day domestic cattle. What little difference there is, say the scientists, could come from different population histories. By analyzing the DNA with computer simulations, they believe the differences in DNA could only have arisen if a small number of animals were domesticated from the wild ox. They believe as few as 80 wild oxen are responsible for what we know now as modern, domestic cattle.
Results of this study are published in the current issue of the journal Molecular Biology and Evolution.
In a press release announcing the results, Dr Ruth Bollongino of CNRS, France, and the University of Mainz, Germany; lead author of the study, said, Getting reliable DNA sequences from remains found in cold environments is routine. That is why mammoths were one of the first extinct species to have their DNA read. But getting reliable DNA from bones found in hot regions is much more difficult because temperature is so critical for DNA survival. This meant we had to be extremely careful that we did not end up reading contaminating DNA sequences from living, or only recently dead cattle.
According to the scientists, it is important to the archeological study of domestication to note the number of original animals.
Prof Mark Thomas, geneticist and an author of the study based at the UCL Research Department of Genetics, Evolution and Environment: This is a surprisingly small number of cattle. We know from archaeological remains that the wild ancestors of modern-day cattle, known as aurochs, were common throughout Asia and Europe, so there would have been plenty of opportunities to capture and domesticate them.
Based at the University of Mainz, Germany, Professor Joachim Burger had this to say about the wild ox, Wild aurochs are very different beasts from modern domestic cattle. They were much bigger than modern cattle, and wouldnt have had the domestic traits we see today, such as docility. So capturing these animals in the first place would not have been easy, and even if some people did manage snare them alive, their continued management and breeding would still have presented considerable challenges until they had been bred for smaller size and more docile behavior.
Other archeological studies have shown other animals, not just cattle, were domesticated. Goats, sheep, and pigs have also been found to be domesticated in the Near East around the beginning of the farming age. It is much harder, however, to determine how many of these animals were domesticated. While traditional archeological techniques do not provide an entire picture as to how many animals were domesticated, genetic research helps to fill in these gaps.
Excerpt from:
DNA Traces Cattle Back To Ancient Times
DNA has confirmed that human remains found near a dry stream in Delta County earlier this month belong to Paige Birgfeld, a Grand Junction woman who went missing in June 2007.
Sgt. Matt Lewis said the DNA match last week was a formality because dental records all but confirmed the remains were those of 34-year-old Birgfeld, a mother of three young children who worked as an escort. Her charred car was found in a Grand Junction parking lot a few days after her disappearance.
Lewis said investigators are awaiting the results of tests by an forensic anthropologist this week or early next. The detailed study of the remains "could help our coroner determine a cause and manner of death, which at this point would be huge."
He said those results might not be made public, however, if releasing them would benefit whoever might be responsible for Birgfeld's death or otherwise jeopardize the investigation.
Frank Birgfeld of Centennial said the area around the dry creek bed where his daughter's remains were found March 7 had been searched thoroughly in 2007. Her checkbook and other items from her purse were found along U.S. 50 not far away after her disappearance.
Read more here:
DNA confirms body found is Grand Junction mom missing since 2007
STONY BROOK, NY--(Marketwire -03/28/12)- Applied DNA Sciences, Inc. (OTC.BB: APDN.OB - News), a provider of DNA-based security, anti-counterfeiting technology, law-enforcement and product-authentication solutions, and Holliston LLC, announced today they are working together to develop the next generation security platform for various product coatings, including passports and luxury packaging materials, with botanical SigNature DNA. As the nation's oldest and largest manufacturer of cloth coverings, Holliston has served the book cover material, packaging fabric, and industrial cloth markets since 1895. Holliston remains the U.S. Government's preferred supplier of high-security passport cover material.
Holliston's Chief Operating Officer, Keith Polak, stated: "We are excited about the prospect of incorporating the botanical SigNature DNA layer into a variety of products to stem the rising threat of forged passports and other identity documents. DNA, we believe, is the gold standard, and we are working toward providing our customers with the best security solution, whilst maintaining the highest quality products to which they are accustomed."
Applied DNA Sciences and Holliston are developing and testing DNA-coatings that essentially cannot be copied, and provide a means for customs and law enforcement groups to authenticate products in the field, and in the lab. The joint work has resulted in a feasibility study that successfully demonstrated the ability to incorporate botanical SigNature DNA onto passport covers. The next phase of the collaboration is to develop working prototypes, and move toward scaling up the process for commercial production.
Dr. James Hayward, APDN CEO and President, stated: "Passport authenticity governs secure entry into the United States for all citizens and visitors. We are pleased to be working with Holliston, the world's largest supplier of secure passport bindings. This effort extends our existing business to enhance government security."
About APDNAPDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature DNA and smartDNA, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.
The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 8, 2011 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
About HollistonICG Holliston is the nation's oldest and largest manufacturer of cloth coatings. At Holliston, we combine innovation, sustainability, and more than a century of experience to produce the highest quality, best-performing cotton cloth in the industry. From book covers to packaging, passports and industrial coverings, Holliston cloth is both distinctive and environmentally friendly -- and, it's made to stand up to the test of time.
No one disputes that the Lawrence Berkeley National Laboratory campus that's coming to Richmond will generate jobs and tax revenues.
But concerns persist about the work that will be done there, especially in synthetic biology, and the risks posed to the surrounding community.
That was among the topics at a news conference and public forum in Berkeley on Wednesday, touted as the first gathering in the area of local, national and international speakers to address concerns about synthetic biology, an emerging science that implants genetic material into cells to produce fuels and other industrial products.
Titled "Bay Area Biotech Labs Bring Unforeseen Risks," the panel presentation at the Center for Genetics and Society featured five prominent critics of synthetic biology.
The national lab, which selected Richmond for its next site thanks in part to broad support among Richmond city leaders, is not all that it appears, said panelist Gopal Dayaneni, co-director of the Movement Generation Justice and Ecology Project.
"What we're experiencing (with LBNL) is a wolf in sheep's clothing," Dayaneni said. "Actually, a wolf genetically engineered to look like a sheep."
Dayaneni, like the other panelists, said the lab enjoys the "shiny veneer" of legitimacy lent by UC Berkeley but is actually a secretive, poorly regulated merger of public and private interests that will be operating on the scientific fringes with potentially
"(Synthetic biology) is genetic engineering on steroids," said Jim Thomas of the ETC Group, a watchdog organization that monitors emerging technologies. "It's a $1.6 billion industry, and the Bay Area is absolutely the heart of that. ... A key institution is the new Richmond lab."
Panelists called for safeguards to bar "human applications" of synthetic biology, a more robust regulatory structure and better protections for workers.
Becky McLain, a molecular biologist who won a 2010 lawsuit against her former employer, pharmaceutical giant Pfizer, said the safety risks that may face workers in Richmond will be even more volatile than those she encountered in an embryonic stem cell lab. A federal jury awarded McLain $1.37 million in damages after she was exposed to a genetically engineered virus that caused her recurring paralysis and other illnesses.
Go here to see the original:
Critics raise safety concerns with biotech labs at Berkeley forum
Three biology students held a symposium to present their research on causes of preterm birth, the mechanism itself and treatment options earlier this month.
Bao-Tran Nguyen, John Schwabe and Siobhan Donnelly presented their theses and will graduate and pass on their part of the research this May.
"We're going to have students working on this for years," Schwabe said. "It's great to be a part of research with this magnitude and breadth, especially as an undergraduate."
A total of ten students are currently working on the project with Chishimba Mowa, an associate professor in the department of biology.
Nguyen said Mowa's lab is one of the few looking specifically at cervical remodeling to understand why preterm births occur.
"Sometimes it's frustrating because there's not a lot of previous studies, so we have to forage our own way and invent the wheel," Nguyen said.
This type of research is important because preterm birth is the leading cause of newborn death, Nguyen said.
Nguyen, Schwabe and Donnelly plan to publish their findings, Schwabe said.
"We're going to be the first people to publish this kind of study on this tissue," Schwabe said. "We've identified proteins previously unstudied in the cervix that may play a pivotal role in controlling natural birth."
Other students working on this research project are looking into herbs like Echinacea as a treatment option for preterm birth, Donnelly said.
Go here to read the rest:
Biology students contribute to science community, preterm birth research
"Cancer Cure Discovered : Guyabano - The Soursop Fruit!" This article was forwarded to us by email by no less than former House of Representatives member and incumbent DavOr vice governor Mayo Almario. We also found out that
posted this on Facebook.
Why are we not aware of this? Because some big corporations want to make back their money spent on years of research by trying to make a synthetic version of it for sale.
So, since you know it now you can help a friend in need by letting him/her know or just drink some sour sop juice yourself as prevention from time to time. The taste is not bad after all. Its completely natural and definitely has no side effects. If you have the space, plant one in your garden. The other parts of the tree are also useful. The next time you have a fruit juice, ask for a SOUR SOP.
How many people died in vain while this billion-dollar drug maker concealed the secret of the miraculous Graviola tree?
This tree is low and is called graviola in Brazil, guanabana in Spanish and has the uninspiring name "sour sop" in English. The fruit is very large and the subacid sweet white pulp is eaten out of hand or, more commonly, used to make fruit drinks, sherbets and such.
The principal interest in this plant is because of its strong anti cancer effects. Although it is effective for a number of medical conditions, it is its anti tumor effect that is of most interest.
This plant is a proven cancer remedy for cancers of all types!
Besides being a cancer remedy, graviola is a broad spectrum antimicrobial agent for both bacterial and fungal infections, is effective against internal parasites and worms, lowers high blood pressure and is used for depression, stress and nervous disorders.
If there ever was a single example that makes it dramatically clear why the existence of Health Sciences Institute is so vital to all concerned and especially Americans like you, it's the incredible story behind the Graviola tree.
The rest is here:
Guyabano - Cancer Cure Discovered?
HYDERABAD: Lack of legislation and awareness coupled with quality and ethical Issues has been deterrent to the growth of stem cell therapy sector in India, where the bio-tech market is expected to achieve a market size of $ 8 billion by 2015, according to a report by the Yes bank.
Special provisions such as 10-year tax benefits, duty exemptions, fast tracking the approval process by giving it a status of orphan drug (as done in the US) are some measures which could be very helpful to become leaders in this sector, the report 'Stem Cells--an emerging Bio-sector' suggested.
"The legislation for this sector still is at the draft stage. A regulatory framework governing the sector, instead of the guidelines existing at present is essential for the proper growth of stem cell research and applications in India. There are also no guidelines regarding pricing which results in certain unproven injections being sold for around Rs 80,000," the report said.
Several companies are taking advantage of the lack of laws governing the stem cell segment and advertise their therapies and clinical trials as ICMR approved.
However, given the multi-tiered system of registration and approvals recommended in the ICMR's guidelines, some of these are based on fraudulent or exaggerated claims. Further, there are also ethical worries on the side-effects of such treatment, it further said.
In India, there are very few players in the stem cell sector and these are all in very nascent stages and industry consolidation with global players entering into the market through mergers and acquisition route could propel industry growth, it opined.
More here:
Stem cell segment in India to touch $8 billion mark by 2015: Report